rs201672011
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS1
The NM_000041.4(APOE):c.91G>A(p.Glu31Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000041.4 missense
Scores
Clinical Significance
Conservation
Publications
- Alzheimer disease 2Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hyperlipoproteinemia type 3Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- lipoprotein glomerulopathyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
- sea-blue histiocyte syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| APOE | NM_000041.4 | c.91G>A | p.Glu31Lys | missense_variant | Exon 3 of 4 | ENST00000252486.9 | NP_000032.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| APOE | ENST00000252486.9 | c.91G>A | p.Glu31Lys | missense_variant | Exon 3 of 4 | 1 | NM_000041.4 | ENSP00000252486.3 | ||
| APOE | ENST00000425718.1 | c.91G>A | p.Glu31Lys | missense_variant | Exon 2 of 3 | 1 | ENSP00000410423.1 | |||
| APOE | ENST00000434152.5 | c.169G>A | p.Glu57Lys | missense_variant | Exon 3 of 4 | 2 | ENSP00000413653.2 | |||
| APOE | ENST00000446996.5 | c.91G>A | p.Glu31Lys | missense_variant | Exon 3 of 4 | 2 | ENSP00000413135.1 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 72AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000120 AC: 30AN: 249636 AF XY: 0.000133 show subpopulations
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461496Hom.: 0 Cov.: 32 AF XY: 0.0000536 AC XY: 39AN XY: 727060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000473 AC: 72AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
APOE5 VARIANT Pathogenic:1
- -
Familial type 3 hyperlipoproteinemia;C0036489:Sea-blue histiocyte syndrome;C1843013:Alzheimer disease 3;C1863051:Alzheimer disease 2;C1864205:Age related macular degeneration 1;C2673196:Lipoprotein glomerulopathy Uncertain:1
- -
not provided Benign:1
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at